
Resonac Holdings (TSE:4004) has called a board meeting for 25 August 2026 to consider a resolution on a partial spin-off of Crasus Chemical, its petrochemical business, drawing fresh attention to the stock.
The board meeting news follows strong momentum in Resonac Holdings’ shares, with a 1 month share price return of 32.55% and a year-to-date share price return of 142.78%. The 1 year total shareholder return of 320.12% points to very strong longer-term gains, despite a softer 90 day share price return that slipped 12.45%.
Compare Resonac Holdings with other restructuring and materials plays by scanning the list of solid balance sheet and fundamentals (41 results) that have been filtered for stronger fundamentals and balance sheet profiles in similar sectors.
After such a sharp rerating and with Resonac Holdings still trading at a sizeable discount to both analyst targets and intrinsic estimates, the question now is whether the market is being prudently cautious or overly conservative on the spin off story.
Resonac Holdings last closed at ¥16,390, compared with a widely followed narrative fair value of ¥28,000. That gap is grounded in explicit assumptions about earnings, margins and valuation multiples rather than sentiment around the Crasus Chemical spin off alone.
The bullish analysts expect earnings to reach ¥273.5 billion (and earnings per share of ¥1361.84) by about August 2029, up from ¥57.8 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as ¥153.6 billion.
Read the complete narrative. Read the complete narrative.
The fair value story for Resonac Holdings leans heavily on expectations of faster earnings growth than revenue, rising profit margins and a richer future earnings multiple. It highlights which assumptions matter most and how they link back to the current price gap.
Result: Fair Value of ¥28,000 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the bullish Resonac Holdings narrative still hinges on the Chemicals segment recovering from recent weakness and on restructuring costs not weighing more heavily on profits.
Find out about the key risks to this Resonac Holdings narrative.
While the fair value narrative points to Resonac Holdings trading at a discount, the current P/E of about 53.8x is more than 4x the JP Chemicals industry average of 12.8x and well above the fair ratio of 29.5x. Could the share price already be baking in a lot of optimism?
See what the numbers say about this price — find out in our valuation breakdown.
With sentiment on Resonac Holdings clearly mixed, now is a good time to look through the numbers and recent news yourself and decide how you feel about the balance of risks and rewards. To help you weigh both sides, start with the 3 key rewards and 2 important warning signs.
If you only focus on Resonac Holdings, you might miss other stocks that better match your goals. Use the Simply Wall Street Screener to compare and broaden your watchlist.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com